Gangliocytoma: outcome of a rare silent pituitary tumour - Sorbonne Université
Journal Articles BMJ Case Reports Year : 2017

Gangliocytoma: outcome of a rare silent pituitary tumour

Abstract

The most common finding in front of a pituitary incidentaloma is a silent pituitary adenoma. We describe a 59 years old woman with a pituitary gangliocytoma and her follow-up after 1 year. Hormonal exploration only evidenced partial corticotropic insufficiency. A trans-sphenoidal surgery was performed due to the tumour's suprasellar expansion. Gangliocytoma is a benign tumour of unknown prevalence, belonging to central nervous system tumour with neuronal differentiation, and 129 cases have been reported in the literature. growth hormone (GH), adrenocorticotropic hormone (ACTH) or prolactin secretions have been reported, as these ganglion cell-like mature neurons are usually mixed with secreting pituitary endocrine cells. We report a case with a pure gangliocytoma devoid of symptomatic endocrine secretion, not surrounded by pituitary endocrine tumour cells. Immunochemistry of the tumour was positive for hypothalamic growth hormone releasing hormone (GHRH) and pituitary hormones, such as GH and ACTH. Hence, this immunoexpression was not associated with peripheral hormonal secretions, suggesting biologically inactive hypothalamopituitary hormones.
Fichier principal
Vignette du fichier
Donadille et al. - 2017 - Gangliocytoma outcome of a rare silent pituitary .pdf (1.09 Mo) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-02948823 , version 1 (25-09-2020)

Identifiers

Cite

Bruno Donadille, Chiara Villa, Stephan Gaillard, Sophie Christin-Maitre. Gangliocytoma: outcome of a rare silent pituitary tumour. BMJ Case Reports, 2017, 2017, pp.bcr2016218859. ⟨10.1136/bcr-2016-218859⟩. ⟨hal-02948823⟩
18 View
37 Download

Altmetric

Share

More